BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ChemDiv, Inc. 

6605 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-794-4860 Fax: 858-794-4931


SEARCH JOBS

ChemDiv, Inc. is a Fully Integrated Target-to-Clinic Contract Research Organization (CRO) headquartered in San Diego, CA USA. The company features multiple research and development (R&D) subsidiaries in Russia, Ukraine and China as well as business and logistics operations around the world. We engage pharmaceutical and biotech partners by offering 'one stop' drug discovery and development services based on a project-, FTE- and risk sharing collaborative modes.


Notably, our professional assistance is always custom-tailored to your R&D Chemistry, Biology and Clinical needs. We pride ourselves on being one of the industry's most experienced CROs that deal with every aspect of both early and clinical development of oncology-, CNS-, metabolic-, anti-inflammatory and antiviral therapies. Our track record spans successful and timely delivery of discovery libraries, target-biased compound sets reflective of modern trends in Chemical Biology, pathway analysis, in vitro/ex vivo and in vivo assay development and implementation, a multitude of modern drug discovery and evaluation platforms all aimed at accelerated R&D. The integrated Discovery outSource™ solutions cover all disciplines needed to bring a project from target ID to Phase II clinical candidate.


Representative examples (for a complete list of services, please visit us at www.chemdiv.com) include protein engineering, production, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK and multiple in vivo efficacy/tox models. Proteomics and biomarker ID capabilities will be added to our portfolio in 2013. Our collaborators range from Pharma/Biotech to academia, foundations and screening centers: every request or project gets equal attention of our expert team.



 Key Statistics


Email: chemdiv@chemdiv.com
Ownership: Private

Web Site: ChemDiv, Inc.
Employees:
Symbol: 
 



Industry
Services






 Company News
ChemDiv, Inc. Receives Multiple Milestones in Major Drug Discovery Collaboration With Eli Lilly and Company (LLY) 12/19/2012 7:03:07 AM    More...
Coare Biostechnology and ChemDiv, Inc. Establish Co-Marketing and Service Collaboration 11/8/2012 8:42:33 AM    More...
UCB, Inc. (UCBJF.PK) and ChemDiv Research Institute Conclude First Phase of Discovery Chemistry Collaboration 6/13/2012 8:48:20 AM    More...
ChemDiv, Inc. Enters Into Research and Collaboration Agreement With Janssen Pharmaceutica N.V. and Tibotec Pharmaceuticals Ltd 12/20/2011 8:47:00 AM    More...
Emerald BioStructures and ChemDiv, Inc. Establish Co-Marketing Collaboration 3/28/2011 9:26:29 AM    More...
ChemDiv, Inc. Opens the Unique Chemistry E-Commerce Store Offering the World's Largest Small Molecule Inventory 1/12/2011 9:32:02 AM    More...
Viriom Selects ChemDiv, Inc. to Develop HIV Program 10/19/2009 12:05:08 PM    More...
Clinical Development Milestones Achieved for Avineuro CNS Collaboration with ChemDiv, Inc. 9/16/2009 11:02:16 AM    More...
ChemDiv, Inc. and iDialog Nominate Novel Inhibitor of Hepatitis C for Clinical Development 9/15/2009 10:46:44 AM    More...
NeuroNascent, Inc. And ChemDiv, Inc. Announce R&D Collaboration For Development Of A Novel CNS Neurogenic Drug Candidate 9/11/2009 1:59:04 PM    More...
12345

//-->